Skip to content
Forest Global Training Partners
Home Services AI Governance AI Navigators Contact Us
AI Navigators AI Use CasesAI RisksAI Hallucinations Topics Entities Sources
  1. Home
  2. AI Risks
  3. FDA approves first genetic test to screen for opioid use…

AI Risks December 21, 2023 · Fierce Biotech

FDA approves first genetic test to screen for opioid use disorderrisks- Fierce Biotech

Fierce Biotech'Explainable'AI discovers new class of antibiotics that stop MRSA in mice. Dec 20, 2023 04:25pm. Passage looks to offload lead program, 2 other …

Read the original at Fierce Biotech ↗

Topics
Healthcare
Mentions
FDA
Tags
AI Use Case
Tracked via
Google Alert “AI Risks”

Related articles

  • Globus Medical to buy neurostim developer Nevro for $250M - Fierce Biotech AI Use Cases · Feb 11, 2025
  • HowAIAccelerates Clinical & Drug Development Timelines | Fierce Biotech AI Risks · Jun 30, 2024
  • Merck bags options on Evaxion's AI-designed vaccine candidates - Fierce Biotech AI Use Cases · Sep 26, 2024
  • AITool Gauges Opioid Use Disorder Risk- Mirage News AI Risks · Jul 08, 2024
  • Trump cancels Biden executive order on AI safety - Fierce Biotech AI Risks · Jan 22, 2025
  • Study shows generative AI can speed up clinical trial enrollment for pennies per patient AI Risks · Jun 21, 2024

AI Navigators is a curated research index from Forest Global Training Partners. Articles belong to their publishers; we link to and summarize them.

Contact